Skip to main content

Month: February 2022

Millrock Provides Company Update

Figure 1 Alaska Project Location Map. Current projects have gold marker. Former projects have black marker.Figure 2 Project locations in which Millrock has ownership and / or royalty interests.Key Highlights – Anticipated 2022 Activity:Drilling on at least four and perhaps as many as eight projects in which Millrock has equity and royalty interests.Treasure Creek, Ester, Fairbanks district, Liberty Bell gold projects, Fairbanks area, Alaska (Felix Gold 15,000 meters planned). 64North gold project, Pogo Mine area, Alaska (Resolution Minerals, planning in progress). Apex El Nido gold project, southeast Alaska (Coeur Explorations, 1,500 meters under consideration). Batamote copper project, Sonora Mexico (Mine Discovery Fund earning in, preliminary planning in progress). El Picacho gold project, Sonora Mexico (Tocvan Ventures, preliminary...

Continue reading

Trust Stamp Launches Privacy-First Identity Orchestration Platform

Delivers security, operational efficiency, and cost benefits unmatched by traditional identity frameworks Atlanta , Feb. 24, 2022 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity CompanyTM providing AI-powered trust and identity services used globally across multiple sectors, announces the launch of its end-to-end Identity Orchestration Platform, which streamlines delivery and implementation of the Company’s proven technologies through a low-code approach. Trust Stamp’s powerful identity platform enables clients to transform security, privacy, and usability in digital operations with a range of leading AI-powered technologies including biometric, document and liveness verification, as well as data-protection and more, in order to support robust identity frameworks that can be established,...

Continue reading

Kinross completes acquisition of Great Bear Resources

TORONTO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX:K; NYSE:KGC) (the “Company”) is pleased to announce today that it has completed the previously announced plan of arrangement (the “Arrangement”) to acquire all of the issued and outstanding shares of Great Bear Resources Ltd. (“Great Bear”). “The closing of the acquisition of Great Bear Resources represents a milestone for Kinross as we advance our future growth strategy. We are excited to add such a high-quality asset in a top mining jurisdiction to our global portfolio,” said J. Paul Rollinson, Kinross Gold President and CEO. “Our exploration and development strategy will start immediately, including our goal of drilling 200,000 metres this year. We aim to further define the asset’s untapped potential and unlock the significant value we see from its numerous...

Continue reading

Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on Rare Disease Day 2022

Ceremony Recognizes Importance of Biopharma Industry and Advocacy Group Collaboration to Address Needs for New Treatments in Orphan and Rare Disorders Together, Will Ring the Nasdaq Opening Bell to Kick-Off Rare Disease Day on February 28, 2022 CORAL GABLES, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that the company is standing with the National Organization for Rare Disorders (NORD), Global Genes, Muscular Dystrophy Association, Myasthenia Gravis Foundation of America, Conquer MG, and Myasthenia Gravis Association, to ring the opening bell of the Nasdaq market on international...

Continue reading

Codex DNA to Present at the Cowen 42nd Annual Healthcare Conference

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 42nd Annual Cowen Healthcare Conference on Wednesday, March 9th at 2:10 pm Eastern time / 11:10 am Pacific Time. Additionally, Todd will participate in a ‘Synthetic Biology Enabling Technologies Panel’ on Monday, March 7th at 10:30 am Eastern time / 7:30 am Pacific Time. The presentation and panel discussion will both be webcast live and can be accessed through a link on the investors section of Codex DNA’s website at https://ir.codexdna.com. An archived replay of each webcast will be available for 30 days following the event. About Codex DNACodex DNA is empowering scientists with the ability...

Continue reading

Pliant Therapeutics to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, will participate in the following conferences in March.Cowen 42nd Annual Health Care Conference: Dr. Coulie will participate in the Respiratory/ Infections panel on Tuesday, March 8, at 2:10 p.m. ET / 11:10 a.m. PT Oppenheimer 32nd Annual Healthcare Conference: Dr. Coulie will present a company update on Wednesday, March 16, at 3:20 p.m. ET / 12:20 p.m. PTInterested parties can access these presentations from the Investor Relations’ Events & Presentation page of Pliant’s website at https://ir.pliantrx.com/news-and-events/events-and-presentations...

Continue reading

Amerigo Reports Record Revenue, Net Income and Cash Balances in 2021

2021 net income of $39.8 million, earnings per share of $0.22 (Cdn$0.28) Annual EBITDA1 of $90.1 million, annual operating cash flow before changes in non-cash working capital1 of $69.5 million Dividend of Cdn$0.03 per share payable on March 21, 2022 VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) is pleased to announce financial results for the year and three months (“Q4-2021”) ended December 31, 2021. Dollar amounts in this news release are in U.S. dollars unless indicated otherwise. Amerigo’s annual financial results included net income of $39.8 million, earnings per share (“EPS”) of $0.22 (Cdn$ 0.28), EBITDA1 of $90.1 million and operating cash flow before changes in working capital1 of $69.5 million. “Amerigo had a robust operational and...

Continue reading

Dynacor Declares March 2022 Monthly Dividend

MONTREAL, Feb. 24, 2022 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) announced its monthly dividend. The declaration of a dividend payment of C$0.0083 per common share will be payable on March 17, 2022, to shareholders of record as of the close of business on March 9, 2022. This dividend represents the twenty-fourth (24th) dividend and (14th) fourteenth monthly payment made to shareholders. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. ABOUT DYNACOR Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal,...

Continue reading

Oma Savings Bank Plc’s Board of Directors decided on a new incentive scheme and an earning period for key persons for 2022-2023

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 24 FEBRUARY 2022 AT 15.01 P.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGEOma Savings Bank Plc’s Board of Directors decided on a new incentive scheme and an earning period for key persons for 2022-2023 The Board of Directors of Own Savings Bank Plc (OmaSp or the Company) has decided to establish a new share-based incentive scheme for key persons of the Group. The aim of the scheme is to combine the interests of owners and key persons in order to increase the value of the Company in the long term, and to commit the key persons to implement the Company’s strategy, objectives and long-term interest and to provide them with competitive earnings of the Company’s shares and a remuneration scheme based on accrual. The share-based incentive scheme is in place until...

Continue reading

Healthcare Triangle (HCTI) Closes Previously Announced Acquisition of DevCool, an Electronic Health Record (EHR) Focused Healthcare IT and Managed Services Company

Acquisition Expected to Add Approximately $20 Million in Revenues PLEASANTON, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc. (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform company announced today that it has completed its previously announced acquisition of DevCool, Inc. (“DevCool”). DevCool provides EHR Implementation and Managed Services to 6 of the top 10 Hospitals in the US and specializes in providing services to cancer research hospitals and university medical centres. Healthcare Triangle completed the transaction for a total consideration of approximately $7.7 million. The acquisition is expected to add approximately $20 million in annual revenues and be accretive to EBITDA. Speaking of the acquisition, Suresh Venkatachari,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.